Endoluminal radiofrequency ablation in patients with malignant biliary obstruction

Endoluminal radiofrequency ablation (RFA) has been promoted as palliative treatment for patients with cholangiocarcinoma (CCA) and pancreatic ductal adenocarcinoma (PDAC) in order to improve biliary drainage and eventually prolong survival. No high level evidence is, however, available on this technique.
This article was published on October 31, 2023, at Gut
DOI:10.1136/gutjnl-2023-329700
gut.bmj.com/content/72/12/2286